[HTML] frontiersin.org

[HTML][HTML] Immunological Considerations for Schistosoma Vaccine Development: Transitioning to Endemic Settings

E Driciru, JPR Koopman, S Cose, AA Siddiqui… - Frontiers in …, 2021 - frontiersin.org
Despite mass drug administration programmes with praziquantel, the prevalence of
schistosomiasis remains high. A vaccine is urgently needed to control transmission of this …
被引用次数：27 相关文章
[HTML] nih.gov

[HTML][HTML] Immunological Considerations for Schistosoma Vaccine Development: Transitioning to Endemic Settings

E Driciru, JPR Koopman, S Cose… - Frontiers in …, 2021 - ncbi.nlm.nih.gov
Despite mass drug administration programmes with praziquantel, the prevalence of
schistosomiasis remains high. A vaccine is urgently needed to control transmission of this …

Immunological Considerations for Schistosoma Vaccine Development: Transitioning to Endemic Settings.

E Driciru, JPR Koopman, S Cose… - Frontiers in …, 2021 - researchonline.lshtm.ac.uk
Despite mass drug administration programmes with praziquantel, the prevalence of
schistosomiasis remains high. A vaccine is urgently needed to control transmission of this …

Immunological considerations for Schistosoma vaccine development: transitioning to endemic settings.

E Driciru, JPR Koopman, S Cose, AA Siddiqui… - 2021 - cabidigitallibrary.org
Despite mass drug administration programmes with praziquantel, the prevalence of
schistosomiasis remains high. A vaccine is urgently needed to control transmission of this …

Immunological Considerations for Schistosoma Vaccine Development: Transitioning to Endemic Settings

E Driciru, JPR Koopman, S Cose… - Frontiers in …, 2021 - pubmed.ncbi.nlm.nih.gov
Despite mass drug administration programmes with praziquantel, the prevalence of
schistosomiasis remains high. A vaccine is urgently needed to control transmission of this …

Immunological Considerations for Schistosoma Vaccine Development: Transitioning to Endemic Settings.

E Driciru, JPR Koopman, S Cose, AA Siddiqui… - Frontiers in …, 2021 - europepmc.org
Despite mass drug administration programmes with praziquantel, the prevalence of
schistosomiasis remains high. A vaccine is urgently needed to control transmission of this …

Immunological considerations for schistosoma vaccine development: transitioning to endemic settings

E Driciru, JPR Koopman… - Frontiers in …, 2021 - scholarlypublications …
Despite mass drug administration programmes with praziquantel, the prevalence of
schistosomiasis remains high. A vaccine is urgently needed to control transmission of this …
[PDF] usp.br

[PDF][PDF] Immunological Considerations for Schistosoma Vaccine Development: Transitioning to Endemic Settings

E Driciru, JPR Koopman, S Cose… - Front. Immunol. 12 …, 2021 - edisciplinas.usp.br
Driciru et al. Immunological Considerations for Schistosoma-Vaccine Development
implementation policies. Besides well-designed studies in different target populations using …

Immunological Considerations for Schistosoma Vaccine Development: Transitioning to Endemic Settings

E Driciru, JPR Koopman, S Cose… - Frontiers in …, 2021 - pubmed.ncbi.nlm.nih.gov
Despite mass drug administration programmes with praziquantel, the prevalence of
schistosomiasis remains high. A vaccine is urgently needed to control transmission of this …

Immunological Considerations for Schistosoma Vaccine Development: Transitioning to Endemic Settings.

E Driciru, JPR Koopman, S Cose, AA Siddiqui… - Frontiers in …, 2021 - europepmc.org
Despite mass drug administration programmes with praziquantel, the prevalence of
schistosomiasis remains high. A vaccine is urgently needed to control transmission of this …